Trulicity Trial Shows Benefits for Type 2 Diabetes

A yearlong clinical trial in more than a dozen countries reveals that once-a-week-Trulicity, used in conjunction with short acting insulin, not only improved blood sugar control for subjects with type 2 diabetes, but also curbed hypoglycemia compared to a standard treatment and reduced weight in trial subjects. Read more

The post Trulicity Trial Shows Benefits for Type 2 Diabetes appeared first on A Sweet Life.